Claritas Pharmaceuticals, Inc. (CLAZF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 1, 2025
Claritas Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '21 Sep 30, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2015 |
| Cash & Equivalents | 0 | 0.01 | 0.03 | 0.23 | 3.69 | 0.67 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.01 | 0.03 | 0.23 | 3.69 | 0.67 | Upgrade
|
| Cash Growth | -99.59% | -84.38% | -85.90% | -93.84% | 447.70% | 8.20% | Upgrade
|
| Other Receivables | 0.1 | 0.21 | 0.12 | 0.52 | 0.11 | 4.14 | Upgrade
|
| Receivables | 0.1 | 0.21 | 0.12 | 0.52 | 0.11 | 4.14 | Upgrade
|
| Prepaid Expenses | 5.58 | 0.76 | - | - | - | - | Upgrade
|
| Total Current Assets | 11.02 | 0.98 | 0.15 | 0.75 | 3.8 | 4.81 | Upgrade
|
| Goodwill | - | 1.77 | 4.69 | 9.47 | 11.5 | - | Upgrade
|
| Other Intangible Assets | - | 7.69 | 20.4 | 49.4 | 49.98 | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | - | - | - | Upgrade
|
| Total Assets | 11.02 | 10.45 | 25.26 | 59.61 | 65.28 | 4.81 | Upgrade
|
| Accounts Payable | 0.37 | 0.91 | 1.56 | 1.66 | 0.58 | 1.35 | Upgrade
|
| Accrued Expenses | 0.96 | 1.07 | 0.58 | 1.33 | 0.72 | 0.24 | Upgrade
|
| Current Portion of Long-Term Debt | 0.54 | 0.93 | 0.36 | 0.25 | - | - | Upgrade
|
| Other Current Liabilities | 5.86 | 4.22 | 3.26 | 4.59 | 2.71 | 0.31 | Upgrade
|
| Total Current Liabilities | 7.73 | 7.13 | 5.76 | 7.82 | 4.01 | 1.9 | Upgrade
|
| Long-Term Debt | - | - | 0.37 | - | 2.87 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 1.77 | 6.65 | 11.28 | 11.5 | - | Upgrade
|
| Other Long-Term Liabilities | 0.01 | 0.04 | 15.9 | 30.75 | 58.54 | - | Upgrade
|
| Total Liabilities | 7.74 | 8.94 | 28.69 | 49.85 | 76.91 | 1.9 | Upgrade
|
| Common Stock | - | - | - | - | 29.37 | - | Upgrade
|
| Additional Paid-In Capital | 62.35 | 56.51 | 55.78 | 47.77 | 3.94 | 15.99 | Upgrade
|
| Retained Earnings | -59.07 | -55.01 | -59.22 | -38.01 | -44.94 | -13.08 | Upgrade
|
| Shareholders' Equity | 3.28 | 1.51 | -3.44 | 9.76 | -11.63 | 2.92 | Upgrade
|
| Total Liabilities & Equity | 11.02 | 10.45 | 25.26 | 59.61 | 65.28 | 4.81 | Upgrade
|
| Total Debt | 0.54 | 0.93 | 0.74 | 0.25 | 2.87 | - | Upgrade
|
| Net Cash (Debt) | -0.54 | -0.92 | -0.7 | -0.02 | 0.82 | 0.67 | Upgrade
|
| Net Cash Growth | - | - | - | - | 21.55% | 8.20% | Upgrade
|
| Net Cash Per Share | -0.02 | -0.03 | -0.03 | -0.00 | 0.13 | 0.46 | Upgrade
|
| Filing Date Shares Outstanding | 35.51 | 29.17 | 25.82 | 23.35 | 6.52 | 3.93 | Upgrade
|
| Total Common Shares Outstanding | 35.41 | 27.3 | 25.82 | 13.48 | 6.52 | 3.93 | Upgrade
|
| Working Capital | 3.28 | -6.15 | -5.61 | -7.07 | -0.21 | 2.92 | Upgrade
|
| Book Value Per Share | 0.09 | 0.06 | -0.13 | 0.72 | -1.78 | 0.74 | Upgrade
|
| Tangible Book Value | 3.28 | -7.96 | -28.53 | -49.1 | -73.11 | 2.92 | Upgrade
|
| Tangible Book Value Per Share | 0.09 | -0.29 | -1.10 | -3.64 | -11.22 | 0.74 | Upgrade
|
Updated Nov 29, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.